Latest Omeprazole Stories
The surprising results of a recent study indicate that the decades long medical practice of prescribing heartburn medications to patients with asthma is ineffective.
Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors, a new study published online in CMAJ has found
PITTSBURGH, Jan. 23 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S.
-Filing also includes age appropriate formulation of 2.5 mg and 5 mg strengths of NEXIUM for Delayed-Release Oral Suspension- WILMINGTON, Del., Dec. 19 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S.
Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that Gerald T. Proehl, president and chief executive officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 12 at 9:55 a.m. Eastern time (6:55 a.m.
By Chaudhry, A S Kochhar, R; Kohli, K K Proton pump inhibitors (PPIs) are extensively metabolized in the liver by CYP2C19, that demonstrates genetic polymorphism with 21 mutant alleles.
Clopidogrel, a drug used in treating coronary artery disease and marketed as Plavix(R), may be less effective when it interacts with acid reducing proton pump inhibitors (PPIs) (e.g., Prilosec(R), Nexium(R)) according to an Aetna (NYSE:AET) analysis published in the September 16th issue of the Journal of the American College of Cardiology.
By Anonymous United States of America - The Food and Drug Administration (FDA) has approved esomeprazole magnesium (Nexium(R)) for short-term use in children 1-11 years of age for the treatment of gastroesophageal reflux disease (GERD).
Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, Gurgaon, India, has announced that under an agreement with AstraZeneca Pharmaceuticals it has launched an authorized generic of Omeprazole 40mg capsules in the US healthcare system.
GURGAON, India and PRINCETON, N.J., July 28 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc.